Medical weight loss program at Aesthoria Med Spa Burr Ridge IL

Medical
Weight Loss
in Burr Ridge

Semaglutide, tirzepatide (Mounjaro/Zepbound), liraglutide — including PCOS. Retatrutide coming soon. Every program reviewed by a physician and our clinical team.

Medical Director: Dr. Jason Wright, DO

About GLP-1 Weight Loss

What GLP-1
medications do

GLP-1 receptor agonists mimic a natural hormone your body already produces. This hormone — glucagon-like peptide-1 — regulates appetite, blood sugar, and digestion. When delivered as a weekly or daily injection, these medications slow stomach emptying, reduce hunger signals, and promote sustained fullness.

The result is not a crash diet. It's a metabolic shift — your body's relationship with food changes at a hormonal level, making caloric reduction feel natural rather than forced. Combined with lifestyle guidance and medical monitoring, most patients see meaningful results within 4–8 weeks.

At Aesthoria, every GLP-1 program is reviewed by Dr. Jason Wright, DO — a licensed physician who evaluates your eligibility, sets your starting dose, monitors your progress, and adjusts your dosage. Our clinical team is available when questions arise.

Healthy lifestyle as part of GLP-1 weight loss at Aesthoria

Our Medications

GLP-1 & GLP-2
programs

The most searched weight loss medications right now — and we offer them all. Each program starts with a free eligibility consultation reviewed by our medical team.

Most Popular
Semaglutide
Ozempic · Wegovy

The most widely studied GLP-1 receptor agonist for weight management. Slows digestion, reduces appetite signals, stabilizes blood sugar. Weekly subcutaneous injection with gradual dose titration.

Weekly injection · self-administered
Gradual dose titration to minimize nausea
Results typically visible at 4–8 weeks
FDA-approved for weight management
Trending
Tirzepatide
Mounjaro · Zepbound

Dual GLP-1 + GIP receptor agonist — targets two metabolic pathways instead of one. Targets two metabolic pathways instead of one for a more comprehensive metabolic effect. A strong option for clients seeking maximum results.

Weekly injection · dual-pathway mechanism
Superior clinical trial outcomes vs. single-agonist
FDA-approved for diabetes & weight management
Ideal for body recomposition alongside aesthetics
Liraglutide
Saxenda · Including PCOS Management

Daily injection GLP-1 with the longest safety track record. Particularly effective for women with PCOS-related weight challenges — addressing insulin resistance, hormonal imbalance, and the specific metabolic profile that makes PCOS weight resistant to diet and exercise alone.

Daily injection · non-weekly option
Longest clinical safety record in class
Effective for PCOS-related weight resistance
FDA-approved for chronic weight management
Coming Soon
Retatrutide
Triple Agonist · GLP-1 / GIP / Glucagon

The next-generation triple receptor agonist generating extraordinary search interest. Early trials show weight loss exceeding both semaglutide and tirzepatide (Mounjaro/Zepbound). Not yet commercially available — Aesthoria is positioning to offer it as soon as accessible.

Triple pathway: GLP-1 + GIP + glucagon
Phase 2 trial results: exceptional data
Currently in late-stage clinical trials
Join the retatrutide waitlist
Summer 2026 Pricing

Monthly program pricing

Free 30-min eligibility consultation required · In-office & at-home options available

10-Week Kickstart Program
$1,199
In-Office
$1,399
At-Home

Includes consults, check-ins, medication, and lab review

Semaglutide — Monthly
0.25 mg/wk$199 in-office$235 at-home
0.50 mg/wk$249$299
1.00 mg/wk$349$425
1.50 mg/wk$399$475
2.00–2.50 mg/wk$475–550$550–625
Tirzepatide — Monthly
2.5 mg/wk$325 in-office$375 at-home
5.0 mg/wk$399$449
7.5 mg/wk$499$579
10.0 mg/wk$625$725
12.5–15.0 mg/wk$775–875$875–999
Free eligibility consultation · Our medical team reviews your medical history · All programs clinically reviewed · Cherry & Affirm financing available · See payment options
Dr. Jason Wright DO Medical Director Aesthoria Med Spa

Your Medical Director

Dr. Jason
Wright, DO

Every GLP-1 program at Aesthoria is reviewed by Dr. Wright — a licensed physician who evaluates your eligibility, sets your starting dose, monitors your labs, and adjusts your titration schedule based on your response. Our team is available when questions arise.

Doctor of Osteopathic MedicineGLP-1 Program DirectorDosage Titration OversightBoard-Certified Plastic Surgeon

The Process

How our program
works

01
Medical Review

Our medical team reviews your medical history, medications, BMI, and goals to determine if you're a candidate and which medication fits your situation.

02
Start Low

Begin at the lowest dose so your body adjusts gradually. This minimizes nausea and side effects. Our medical team sets your starting protocol.

03
Titrate Up

Over 4–8 weeks, your dose increases based on your tolerance and response. Regular check-ins ensure safe, steady progress.

04
Sustain

Once at target dose, the focus shifts to sustaining results. Ongoing medical monitoring and lifestyle guidance keep you on track long-term.

You may be a candidate if

  • BMI of 30 or above (obesity)
  • BMI of 27+ with hypertension, insulin resistance, high cholesterol, or type 2 diabetes
  • PCOS with weight-related metabolic challenges
  • Struggled with diet and exercise alone
  • Not pregnant or breastfeeding

This program is not for you if

  • Pregnant, planning pregnancy, or breastfeeding
  • History of medullary thyroid carcinoma
  • Multiple Endocrine Neoplasia syndrome type 2
  • History of pancreatitis
  • Type 1 diabetes
  • Allergic to GLP-1 medication ingredients

Not sure? That's what the free consultation is for. Our team will give you a clear answer.

Frequently Asked

Your weight loss
questions, answered

Semaglutide is a GLP-1 receptor agonist that mimics a natural hormone regulating appetite and blood sugar. It slows digestion, reduces hunger signals, and promotes fullness. Administered as a weekly injection, it helps patients achieve sustainable weight loss. Brand names include Ozempic and Wegovy.
Tirzepatide (Mounjaro/Zepbound) targets both GLP-1 and GIP receptors — two metabolic pathways instead of one. Clinical trials showed greater average weight loss than semaglutide alone. Our team will recommend which fits your metabolic profile during your free consultation.
Yes. Liraglutide (Saxenda) is particularly effective for PCOS-related weight challenges because it addresses insulin resistance and hormonal imbalance. It’s a daily injection with the longest clinical safety record in the GLP-1 class. Reviewed by Dr. Wright and our clinical team.
Retatrutide is a next-generation triple agonist targeting GLP-1, GIP, and glucagon pathways simultaneously. Phase 2 data showed extraordinary weight loss. Currently in late-stage trials. Aesthoria will offer it when available — join our waitlist to be first.
Typically individuals with BMI 30+, or BMI 27+ with a weight-related condition (hypertension, insulin resistance, high cholesterol, type 2 diabetes, PCOS). A free eligibility consultation with our medical team is required before starting.
Semaglutide and liraglutide are FDA-approved for weight management. Tirzepatide is FDA-approved for diabetes and weight management. All Aesthoria programs are reviewed by Dr. Jason Wright, DO, with ongoing monitoring and dosage adjustment by our clinical team.
Most patients notice reduced appetite within 1–2 weeks. Visible weight loss at 4–8 weeks as dosage increases. Significant results by 3–6 months with consistent treatment and lifestyle modifications.
Nausea is most common, especially during dose increases, and typically diminishes as your body adjusts. Other effects may include headache, fatigue, and digestive changes. Starting low and titrating gradually minimizes these — which is why Dr. Wright sets a personalized schedule.
Weight regain is possible without maintaining lifestyle changes — true of any weight intervention. The goal is to use medication to reset your metabolic baseline while building sustainable habits. Dr. Wright plans your long-term strategy including when and how to taper.
Yes — many clients do. Weight loss often reveals areas for body contouring, skin tightening, or volume restoration. Sculptra, Kybella, IV hydration, and microneedling pair naturally with GLP-1. Layanna and Dr. Wright collaborate on combined plans.

Take the first step

Your free eligibility
consultation

Our medical team will review your medical history, explain which medication fits your goals, and give you a clear answer. No pressure. No commitment. Free.